INSTGRA DOLUTEGRAVIR TABLETS

Get a Price/Quote

INSTGRA DOLUTEGRAVIR TABLETS Specification

Dosage Form
Tablet

Indication
For the treatment of HIV-1 infection

Origin of Medicine
India

Salt Composition
Dolutegravir 50 mg

Pacakaging (Quantity Per Box)
30 Tablets per box

Drug Type
Allopathic

Ingredients
Dolutegravir

Physical Form
Tablets

Function
Antiretroviral (Integrase Inhibitor)

Recommended For
HIV-1 Infected Patients

Dosage
50 mg

Dosage Guidelines
As directed by the physician

Suitable For
Adults

Quantity
30 Tablets

Storage Instructions
Store in a cool, dry place below 30C. Protect from light and moisture.

Packing Type
HDPE Bottle

Prescription/Non Prescription
Prescription

Route of Administration
Oral

Marketed By
Emcure

Brand Name
INSTGRA

Shelf Life
24 months

Registration Required
Yes

INSTGRA DOLUTEGRAVIR TABLETS Trade Information

Main Domestic Market
All India

About INSTGRA DOLUTEGRAVIR TABLETS

Instgra 50 Mg

Specifications :-

Strength:50 mg
Form:Tablet
Manufacturer:Emcure
Brand:INSTGRA
Packaging Size:Pack of 30 Tablets
Composition:Dolutegravir

Note :- INSTGRA Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug................

Advanced Treatment for HIV-1 Infection

INSTGRA Dolutegravir Tablets offer an effective solution for adults diagnosed with HIV-1 infection. The integrase inhibitor mechanism blocks viral replication, helping slow disease progression and improve patient outcomes when taken as directed by a physician. Adherence to prescribed dosage ensures optimal therapeutic benefit.

Precision Formulation and Secure Packaging

Every tablet contains 50 mg of Dolutegravir, presented in a robust HDPE bottle that preserves the medications integrity. Registration is required for procurement, ensuring medications are distributed responsibly by certified suppliers, distributors, and traders across India.

Safe Storage and Administration

To maintain potency and safety, INSTGRA should be stored below 30C, protected from light and moisture. Tablets should be taken orally, exactly as the physician recommends, reinforcing safe and effective medication use for HIV-1 infected patients.

FAQs of INSTGRA DOLUTEGRAVIR TABLETS:

Q: How should INSTGRA Dolutegravir Tablets be taken?

A: INSTGRA Dolutegravir Tablets are taken orally, following the physicians prescribed dosing guidelines. The recommended dosage is typically 50 mg once daily for adults, but always follow your healthcare providers exact instructions.

Q: What is the main benefit of using INSTGRA Dolutegravir Tablets?

A: The main benefit of INSTGRA is its ability to inhibit HIV integrase, thereby preventing the replication of HIV-1 in the body. This helps manage the infection and may improve overall health outcomes for patients.

Q: When should I take my INSTGRA Dolutegravir dose?

A: INSTGRA should be taken at a consistent time each day, as directed by your physician, to maintain stable drug levels in the body. Do not skip doses or change the schedule without consulting your healthcare provider.

Q: Where should I store INSTGRA Dolutegravir Tablets?

A: Store INSTGRA Dolutegravir Tablets in a cool, dry place below 30C, away from light and moisture, to preserve their effectiveness.

Q: What process is needed to obtain INSTGRA Dolutegravir Tablets?

A: INSTGRA is a prescription-only medication that requires registration. Patients must consult a licensed healthcare professional, obtain a valid prescription, and then purchase it from authorized suppliers or pharmacies.

Q: Is INSTGRA suitable for everyone with HIV-1 infection?

A: INSTGRA is recommended for HIV-1 infected adults. Your physician will determine if it is appropriate for your individual health needs based on your medical history and other factors.

Q: Does INSTGRA Dolutegravir interact with other medicines?

A: INSTGRA Dolutegravir may interact with certain medications. Inform your physician about all medicines and supplements you are taking to avoid potential drug interactions and ensure maximum safety.

Tell us about your requirement